fosinopril sodium - Profile

What are the generic sources for fosinopril sodium and what is the scope of freedom to operate?

Fosinopril sodium is the generic ingredient in four branded drugs marketed by Actavis Labs Fl Inc, Apotex, Aurobindo Pharma Ltd, Chartwell Rx, Invagen Pharms, Prinston Inc, Ranbaxy Labs Ltd, Teva, Upsher Smith Labs, Watson Labs, Bristol Myers Squibb, Ani Pharms, Aurobindo Pharma, Mylan, Sandoz, and Sun Pharm Inds Ltd, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

Summary for fosinopril sodium

US Patents:	0
Tradenames:	4
Applicants:	16
NDAs:	22

US Patents and Regulatory Information for fosinopril sodium

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Labs Fl Inc	FOSINOPRIL SODIUM	fosinopril sodium	TABLET;ORAL	076620-001	Oct 15, 2004		DISCN	No	No
Actavis Labs Fl Inc	FOSINOPRIL SODIUM	fosinopril sodium	TABLET;ORAL	076620-002	Oct 15, 2004		DISCN	No	No
Actavis Labs Fl Inc	FOSINOPRIL SODIUM	fosinopril sodium	TABLET;ORAL	076620-003	Oct 15, 2004		DISCN	No	No
Apotex	FOSINOPRIL SODIUM	fosinopril sodium	TABLET;ORAL	076906-001	May 17, 2005		DISCN	No	No
Apotex	FOSINOPRIL SODIUM	fosinopril sodium	TABLET;ORAL	076906-002	May 17, 2005		DISCN	No	No
Apotex	FOSINOPRIL SODIUM	fosinopril sodium	TABLET;ORAL	076906-003	May 17, 2005		DISCN	No	No
Aurobindo Pharma Ltd	FOSINOPRIL SODIUM	fosinopril sodium	TABLET;ORAL	091163-001	Mar 30, 2011	AB	RX	No	No

Expired US Patents for fosinopril sodium

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bristol Myers Squibb	MONOPRIL	fosinopril sodium	TABLET;ORAL	019915-002	May 16, 1991
Bristol Myers Squibb	MONOPRIL	fosinopril sodium	TABLET;ORAL	019915-004	Mar 28, 1995
Bristol Myers Squibb	MONOPRIL	fosinopril sodium	TABLET;ORAL	019915-003	May 16, 1991